Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
For percentage of patients achieving specified reduction in disease activity, iberdomide superior to placebo only at highest dose tested
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.